Fluent: Illumina's Acquisition of Fluent BioSciences
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging [...]
Read full article »
CEO
Brian McKernan
Fluent is a Massachusetts-based biotechnology company that researches, develops and markets single-cell RNA kits for the treatment of cancer and infectious diseases.
Read more